Showing 19,761 - 19,780 results of 21,342 for search '(( ((significant amount) OR (significant effects)) decrease ) OR ( significant decrease decrease ))', query time: 0.54s Refine Results
  1. 19761

    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

    Published 2024
    “…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”
  2. 19762

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”
  3. 19763

    Data Sheet 11_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  4. 19764

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”
  5. 19765

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”
  6. 19766

    Data Sheet 3_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  7. 19767

    Data Sheet 8_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  8. 19768

    Data Sheet 5_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  9. 19769

    Table 1_The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery.docx by Natalia Pavone (9442097)

    Published 2024
    “…The sensitivity of both valve culture and 16srRNA decreased significantly with prolonged preoperative antibiotic therapy. …”
  10. 19770

    Data Sheet 15_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  11. 19771

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Known associations between genomic alterations and immunotherapy markers were observed including significantly lower TMB levels in tumors with therapy-associated alterations and significantly higher PD-L1 levels in tumors with ALK, MET, BRAF, or ROS1 driver mutations. …”
  12. 19772

    Data Sheet 10_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  13. 19773

    Data Sheet 13_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  14. 19774

    Data Sheet 4_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  15. 19775

    Data Sheet 7_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  16. 19776

    Image 3_The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery.tiff by Natalia Pavone (9442097)

    Published 2024
    “…The sensitivity of both valve culture and 16srRNA decreased significantly with prolonged preoperative antibiotic therapy. …”
  17. 19777

    Image 1_The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery.tiff by Natalia Pavone (9442097)

    Published 2024
    “…The sensitivity of both valve culture and 16srRNA decreased significantly with prolonged preoperative antibiotic therapy. …”
  18. 19778

    Image 2_The expanding role of 16s ribosomal RNA PCR in the management of patients with infective endocarditis undergoing cardiac surgery.tiff by Natalia Pavone (9442097)

    Published 2024
    “…The sensitivity of both valve culture and 16srRNA decreased significantly with prolonged preoperative antibiotic therapy. …”
  19. 19779

    Conditional Knockout of Serine Racemase in Microglia Alleviates Alzheimer -like Pathology and Behavior by Reducing Neuroinflammation through Enhancing Histone Lactylation by shengzhou Wu (22341388)

    Published 2025
    “…In the aging brain, SR expression decreases in neurons, while it becomes more abundant in glia cells in AD. …”
  20. 19780

    Data Sheet 14_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”